Global Oscillatory Positive Expiratory Pressure (OPEP) Market, By Product Type (Facemask OPEP Devices, Mouthpiece OPEP Devices, Bottle OPEP Devices), Indication (COPD, Asthma, Atelectasis, Bronchitis, Bronchiectasis, Cystic Fibrosis, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies/Online Sales), End-User (Hospitals, Ophthalmic Clinics, Others), Application (Breathing, Coughing, Others) – Industry Trends and Forecast to 2029.
Oscillatory Positive Expiratory Pressure (OPEP) Market Analysis and Size
According to a CDC (Center for Disease Control and Prevention) report, approximately one in every thirteen Americans suffers from asthma annually. This equates to a patient population of approximately 25 million in the United States alone. Furthermore, the availability of advanced medical infrastructure and early access to new devices and products is assisting in developing the market in the United States.
Data Bridge Market Research analyses that the oscillatory positive expiratory pressure (OPEP) market which was USD 2,529.31 million in 2021, is expected to reach USD 3765.51 million by 2029, at a CAGR of 5.1% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Oscillatory Positive Expiratory Pressure (OPEP) Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Facemask OPEP Devices, Mouthpiece OPEP Devices, Bottle OPEP Devices), Indication (COPD, Asthma, Atelectasis, Bronchitis, Bronchiectasis, Cystic Fibrosis, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies/Online Sales), End-User (Hospitals, Ophthalmic Clinics, Others), Application (Breathing, Coughing, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
D-R BURTON HEALTHCARE (U.S.), Monaghan (U.S.), ICU Medical, Inc. (U.S.), Allergan (Ireland), Trudell Medical International (Canada), CEGLA Medizintechnik GmbH & Co. KG (Germany), Medica Holdings, LLC (U.S.), and AirPhysio (Australia), GaleMed Corporation (China), PARI GmbH (Germany)
|
|
Market Opportunities
|
|
Market Definition
Oscillating positive expiratory pressure (OPEP) is a therapeutic method involving breathing into an expiratory resistance device to remove excess secretion from patients' lungs. As the gas trapping decreases, the method improves lung ventilation capabilities. This therapy mode is a non-pharmacological therapy method that focuses on eliminating mucus hypersecretion, resulting in improved mobility.
Global Oscillatory Positive Expiratory Pressure (OPEP) Market Dynamics
Drivers
- Rising patient awareness
Rising patient awareness for creating a common platform for COPD patients drives the market growth during the forecast period. For instance, November is designated National COPD Awareness Month worldwide. Throughout the month, the COPD Foundation collaborates with various respiratory healthcare organizations to host a variety of in-person and online activities for COPD community members to increase awareness. These are the factors which propels the market growth.
- Rise in chronic obstructive pulmonary disease (COPD)
COPD is caused by an obstruction in the airways, causing difficulty breathing and is primarily caused by tobacco smoking. According to a 2019 WHO (World Health Organization) report, chronic obstructive pulmonary disease is the third leading cause of death worldwide. According to a 2019 World Health Organization (WHO) report, COPD is the third leading cause of death worldwide. Cystic Fibrosis (CF) is a genetic disorder that affects many organs, most notably the lungs. It is estimated that the frequency of heterozygote in white people is one in every twenty. The Cystic Fibrosis Trust reported a significant increase in the CF patient registry in the United Kingdom alone, from 10,338 in 2012 to 10,509 in 2018. This drives the oscillatory positive expiratory pressure (OPEP) market.
Opportunities
- Rising usage of oscillatory positive expiratory pressure (OPEP)
The oscillatory positive expiratory pressure (OPEP) devices have emerged as a viable non-pharmacological therapy option for increasing mobilisation. Furthermore, these devices are used to eliminate mucus hypersecretions in the airways. As a result, such factors have aided in popularising market adoption. With mucus plug viscoelastic functions dwindling, oscillating positive expiratory pressure (OPEP) devices aid in reducing breathlessness, avoiding recurring infections, reducing re-hospitalization. Such advantages of using oscillating positive expiratory pressure (OPEP) devices have thus contributed to the global market's overall growth in recent years.
Restraints/Challenges
- High cost of oscillatory positive expiratory pressure
High cost of oscillatory positive expiratory pressure (OPEP) and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. Lower awareness about the OPEP devices and limited product availability are also hampering the growth of the market.
This oscillatory positive expiratory pressure (OPEP) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oscillatory positive expiratory pressure (OPEP) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent developments
- In June 2019, Solopep, an Irish medical device startup, announced that it had developed a disposable oscillating positive expiratory pressure (OPEP) device for patients with bronchiectasis, cystic fibrosis, and COPD.
- In May 2021, Monaghan Medical Corporation (Monaghan) and Captis announced a three-year contract agreement, forming a partnership between two industry leaders. The sole source agreement acknowledges Monaghan's patient outcome evidence, gold standard medical devices, and Captis' desire to drive process efficiencies and value-driven healthcare spending.
Global Oscillatory Positive Expiratory Pressure (OPEP) Market Scope
The oscillatory positive expiratory pressure (OPEP) market is segmented on the basis of product type, indication, end user, application and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Facemask OPEP Devices
- Mouthpiece OPEP Devices
- Bottle OPEP Devices
Indication
- COPD
- Asthma
- Atelectasis
- Bronchitis
- Bronchiectasis
- Cystic Fibrosis
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies/Online Sales
End-User
- Hospitals
- Ophthalmic Clinics
- Others
Application
- Breathing
- Coughing
- Others
Oscillatory Positive Expiratory Pressure (OPEP) Market Regional Analysis/Insights
The oscillatory positive expiratory pressure (OPEP) market is analyzed and market size insights and trends are provided by country, product type, indication, end user, application and distribution channel as referenced above.
The countries covered in the oscillatory positive expiratory pressure (OPEP) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the oscillatory positive expiratory pressure (OPEP) market due to quick adoption of advanced technologies within the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to rise in the number of patients in the region, growing patient pool and increasing spending on the development of the healthcare infrastructure by the developing economies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The oscillatory positive expiratory pressure (OPEP) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for oscillatory positive expiratory pressure (OPEP) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the oscillatory positive expiratory pressure (OPEP) market. The data is available for historic period 2010-2020.
Competitive Landscape and Oscillatory Positive Expiratory Pressure (OPEP) Market Share Analysis
The oscillatory positive expiratory pressure (OPEP) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to oscillatory positive expiratory pressure (OPEP) market.
Some of the major players operating in the oscillatory positive expiratory pressure (OPEP) market are:
- D-R BURTON HEALTHCARE (U.S.)
- Monaghan (U.S.)
- ICU Medical, Inc. (U.S.)
- Allergan (Ireland)
- Trudell Medical International (Canada)
- CEGLA Medizintechnik GmbH & Co. KG (Germany)
- Medica Holdings, LLC (U.S.)
- AirPhysio (Australia)
- GaleMed Corporation (China)
- PARI GmbH (Germany)
SKU-